Replies to post #43470 on Biotech Values

[DewDiligence]

> NMTI – Are you still watching them?<

I haven’t followed them closely since 2005, when I bought some on the cheap (#msg-5041574).

>I read the panel discussion were positive for them, resulting in a reduction in patient enrollment requirement from 1,600 to 1,000 in the PFO trials.<

I’m not sure which panel you’re referring to. I guess this means I’m even more out of touch than I thought :-)